Accuracy and Safety of a Novel Intravenous Continuous Glucose Monitoring System in Patients Admitted to a Cardiothoracic ICU: A Pilot Trial
Authors' conclusion
The present findings indicate that the investigated intravenous glucose monitoring system provides accurate glucose monitoring and demonstrates its safety in critical care settings.
Study context
- Population
- Patients with and without diabetes admitted to a cardiothoracic surgery ICU
- Participants
- 28 patients1,224 data pairs
- Comparison
- Intravenous CGM vs arterial glucose
- Outcome
- Accuracy and safety of the ivCGM system vs arterial glucose, glucose range 20 to 400 mg/dL
- Follow-up
- Up to 72 hours
Methodological detailssingle-center, open-label
- Single-center
- Open-label
Main finding
As reported in the abstract
Accuracy of ivCGM vs arterial glucose (BGA)
Mean absolute relative difference (MARD)
8.7 ± 7.8%
Mean absolute difference (MAD) for values <100 mg/dL
3.3 ± 2.7 mg/dL
Further findings
| Outcome | Values |
|---|---|
| MARD in participants with diabetes | ivCGM MARD 9.6 ± 8.1 % |
- MARD in participants with diabetes: N = 8,332 ivCGM/BGA data pairs
Safety
- Serious adverse events associated with the device
- 0
Original publication
Accuracy and Safety of a Novel Intravenous Continuous Glucose Monitoring System in Patients Admitted to a Cardiothoracic ICU: A Pilot Trial. J Diabetes Sci Technol. Published 24 May 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →